Survey of tuberculosis drug resistance among Tibetan refugees in India

F. Salvo, Kunchok Dorjee, K. Dierberg, W. Cronin, T. D. Sadutshang, G. B. Migliori, C. Rodrigues, F. Trentini, C. Di Serio, Richard E Chaisson, D. M. Cirillo

Research output: Contribution to journalArticle

Abstract

SETTING: Tuberculosis (TB) is a major health problem among Tibetans living in exile in India. Although drug-resistant TB is considered common in clinical practice, precise data are lacking. OBJECTIVE: To determine the proportion of drug-resistant cases among new and previously treated Tibetan TB patients. DESIGN: In a drug resistance survey in five Tibetan settlements in India, culture and drug susceptibility testing (DST) for first-line drugs were performed among all consecutive new and previously treated TB cases from April 2010 to September 2011. DST against kanamycin (KM), ethionamide, para-aminosalicylic acid and ofloxacin (OFX) was performed on multidrug-resistant TB (MDR-TB) isolates. RESULTS: Of 307 patients enrolled in the study, 264 (193 new and 71 previously treated) were culture-positive and had DST available. All patients tested for the human immunodeficiency virus (n = 250) were negative. Among new TB cases, 14.5% had MDR-TB and 5.7% were isoniazid (INH) monoresistant. Among previously treated cases, 31.4% had MDR-TB and 12.7% were INH-monoresistant. Of the MDR-TB isolates, 28.6% of new and 26.1% of previously treated cases were OFX-resistant, while 7.1% of new cases and 8.7% of previously treated cases were KM-resistant. Three patients had extensively drug-resistant TB. CONCLUSIONS: MDR-TB is common in new and previously treated Tibetans in India, who also show additional complex resistance patterns. Of particular concern is the high percentage of MDR-TB strains resistant to OFX, KM or both.

Original languageEnglish (US)
JournalInternational Journal of Tuberculosis and Lung Disease
Volume18
Issue number6
DOIs
StatePublished - Jun 1 2014

Fingerprint

Refugees
Drug Resistance
India
Tuberculosis
Kanamycin
Ofloxacin
Multidrug-Resistant Tuberculosis
Pharmaceutical Preparations
Extensively Drug-Resistant Tuberculosis
Ethionamide
Aminosalicylic Acid
Isoniazid
Surveys and Questionnaires
HIV
Health

Keywords

  • Drug resistance survey
  • MDR-TB
  • Tibetan refugees
  • Tuberculosis in refugees

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Survey of tuberculosis drug resistance among Tibetan refugees in India. / Salvo, F.; Dorjee, Kunchok; Dierberg, K.; Cronin, W.; Sadutshang, T. D.; Migliori, G. B.; Rodrigues, C.; Trentini, F.; Di Serio, C.; Chaisson, Richard E; Cirillo, D. M.

In: International Journal of Tuberculosis and Lung Disease, Vol. 18, No. 6, 01.06.2014.

Research output: Contribution to journalArticle

Salvo, F, Dorjee, K, Dierberg, K, Cronin, W, Sadutshang, TD, Migliori, GB, Rodrigues, C, Trentini, F, Di Serio, C, Chaisson, RE & Cirillo, DM 2014, 'Survey of tuberculosis drug resistance among Tibetan refugees in India', International Journal of Tuberculosis and Lung Disease, vol. 18, no. 6. https://doi.org/10.5588/ijtld.13.0516
Salvo, F. ; Dorjee, Kunchok ; Dierberg, K. ; Cronin, W. ; Sadutshang, T. D. ; Migliori, G. B. ; Rodrigues, C. ; Trentini, F. ; Di Serio, C. ; Chaisson, Richard E ; Cirillo, D. M. / Survey of tuberculosis drug resistance among Tibetan refugees in India. In: International Journal of Tuberculosis and Lung Disease. 2014 ; Vol. 18, No. 6.
@article{de6148db0efa4271905c47bf165d3c47,
title = "Survey of tuberculosis drug resistance among Tibetan refugees in India",
abstract = "SETTING: Tuberculosis (TB) is a major health problem among Tibetans living in exile in India. Although drug-resistant TB is considered common in clinical practice, precise data are lacking. OBJECTIVE: To determine the proportion of drug-resistant cases among new and previously treated Tibetan TB patients. DESIGN: In a drug resistance survey in five Tibetan settlements in India, culture and drug susceptibility testing (DST) for first-line drugs were performed among all consecutive new and previously treated TB cases from April 2010 to September 2011. DST against kanamycin (KM), ethionamide, para-aminosalicylic acid and ofloxacin (OFX) was performed on multidrug-resistant TB (MDR-TB) isolates. RESULTS: Of 307 patients enrolled in the study, 264 (193 new and 71 previously treated) were culture-positive and had DST available. All patients tested for the human immunodeficiency virus (n = 250) were negative. Among new TB cases, 14.5{\%} had MDR-TB and 5.7{\%} were isoniazid (INH) monoresistant. Among previously treated cases, 31.4{\%} had MDR-TB and 12.7{\%} were INH-monoresistant. Of the MDR-TB isolates, 28.6{\%} of new and 26.1{\%} of previously treated cases were OFX-resistant, while 7.1{\%} of new cases and 8.7{\%} of previously treated cases were KM-resistant. Three patients had extensively drug-resistant TB. CONCLUSIONS: MDR-TB is common in new and previously treated Tibetans in India, who also show additional complex resistance patterns. Of particular concern is the high percentage of MDR-TB strains resistant to OFX, KM or both.",
keywords = "Drug resistance survey, MDR-TB, Tibetan refugees, Tuberculosis in refugees",
author = "F. Salvo and Kunchok Dorjee and K. Dierberg and W. Cronin and Sadutshang, {T. D.} and Migliori, {G. B.} and C. Rodrigues and F. Trentini and {Di Serio}, C. and Chaisson, {Richard E} and Cirillo, {D. M.}",
year = "2014",
month = "6",
day = "1",
doi = "10.5588/ijtld.13.0516",
language = "English (US)",
volume = "18",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "6",

}

TY - JOUR

T1 - Survey of tuberculosis drug resistance among Tibetan refugees in India

AU - Salvo, F.

AU - Dorjee, Kunchok

AU - Dierberg, K.

AU - Cronin, W.

AU - Sadutshang, T. D.

AU - Migliori, G. B.

AU - Rodrigues, C.

AU - Trentini, F.

AU - Di Serio, C.

AU - Chaisson, Richard E

AU - Cirillo, D. M.

PY - 2014/6/1

Y1 - 2014/6/1

N2 - SETTING: Tuberculosis (TB) is a major health problem among Tibetans living in exile in India. Although drug-resistant TB is considered common in clinical practice, precise data are lacking. OBJECTIVE: To determine the proportion of drug-resistant cases among new and previously treated Tibetan TB patients. DESIGN: In a drug resistance survey in five Tibetan settlements in India, culture and drug susceptibility testing (DST) for first-line drugs were performed among all consecutive new and previously treated TB cases from April 2010 to September 2011. DST against kanamycin (KM), ethionamide, para-aminosalicylic acid and ofloxacin (OFX) was performed on multidrug-resistant TB (MDR-TB) isolates. RESULTS: Of 307 patients enrolled in the study, 264 (193 new and 71 previously treated) were culture-positive and had DST available. All patients tested for the human immunodeficiency virus (n = 250) were negative. Among new TB cases, 14.5% had MDR-TB and 5.7% were isoniazid (INH) monoresistant. Among previously treated cases, 31.4% had MDR-TB and 12.7% were INH-monoresistant. Of the MDR-TB isolates, 28.6% of new and 26.1% of previously treated cases were OFX-resistant, while 7.1% of new cases and 8.7% of previously treated cases were KM-resistant. Three patients had extensively drug-resistant TB. CONCLUSIONS: MDR-TB is common in new and previously treated Tibetans in India, who also show additional complex resistance patterns. Of particular concern is the high percentage of MDR-TB strains resistant to OFX, KM or both.

AB - SETTING: Tuberculosis (TB) is a major health problem among Tibetans living in exile in India. Although drug-resistant TB is considered common in clinical practice, precise data are lacking. OBJECTIVE: To determine the proportion of drug-resistant cases among new and previously treated Tibetan TB patients. DESIGN: In a drug resistance survey in five Tibetan settlements in India, culture and drug susceptibility testing (DST) for first-line drugs were performed among all consecutive new and previously treated TB cases from April 2010 to September 2011. DST against kanamycin (KM), ethionamide, para-aminosalicylic acid and ofloxacin (OFX) was performed on multidrug-resistant TB (MDR-TB) isolates. RESULTS: Of 307 patients enrolled in the study, 264 (193 new and 71 previously treated) were culture-positive and had DST available. All patients tested for the human immunodeficiency virus (n = 250) were negative. Among new TB cases, 14.5% had MDR-TB and 5.7% were isoniazid (INH) monoresistant. Among previously treated cases, 31.4% had MDR-TB and 12.7% were INH-monoresistant. Of the MDR-TB isolates, 28.6% of new and 26.1% of previously treated cases were OFX-resistant, while 7.1% of new cases and 8.7% of previously treated cases were KM-resistant. Three patients had extensively drug-resistant TB. CONCLUSIONS: MDR-TB is common in new and previously treated Tibetans in India, who also show additional complex resistance patterns. Of particular concern is the high percentage of MDR-TB strains resistant to OFX, KM or both.

KW - Drug resistance survey

KW - MDR-TB

KW - Tibetan refugees

KW - Tuberculosis in refugees

UR - http://www.scopus.com/inward/record.url?scp=84901269030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901269030&partnerID=8YFLogxK

U2 - 10.5588/ijtld.13.0516

DO - 10.5588/ijtld.13.0516

M3 - Article

C2 - 24903934

AN - SCOPUS:84901269030

VL - 18

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 6

ER -